The American College of Chest Physicians has released clinical practice guidelines for the perioperative management of antithrombotic therapy. These guidelines can be utilized for treating patients receiving vitamin K antagonists (VKA), especially warfarin , direct oral anticoagulant (DOAC), antiplatelet drugs, and requiring invasive procedures or surgery.
Here are the major recommendations from the guidelines! Recommendations for patients receiving VKA therapy Do not perform heparin bridging in patients with – Mechanical heart valve and requiring VKA interruption for an elective procedure or surgery Atrial fibrillation and requiring VKA interruption for an elective procedure or surgery Venous thromboembolism and requiring VKA interruption for an elective procedure or surgery Continue administration of VKA instead of VKA interruption and heparin bridging in patients requiring a…
